Antibacterial activity of ceftriaxone against various clinical strains isolated in 2004

Japanese Journal of Antibiotics

Volumn 58, Issue 3, 2005, Pages 283-289

  Matsuzaki, Kaoru ^a   Shito, Kumiko ^a   Watabe, Emiko ^a   Hasegawa, Miyuki ^a   Sato, Yumie ^a   Kobayashi, Intetsu ^a  

^a LSI MEDIENCE CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFEPIME; CEFOTIAM; CEFTRIAXONE; FLOMOXEF; LEVOFLOXACIN; MEROPENEM; PENICILLIN G; SULPERAZON; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; DRUG POTENCY; GROWTH INHIBITION; HUMAN; JAPAN; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; CEFTRIAXONE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HAEMOPHILUS; HUMANS; KLEBSIELLA PNEUMONIAE; NEISSERIA GONORRHOEAE; STREPTOCOCCUS;

EID: 22444439374     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ceftriaxone (Ro 13-9904) Chemother. 32 (S-7): 1-15, 1984
2. Ceftriaxone (Ro 13-9904) β-lactamase Chemother. 32 (S-7): 16-21, 1984
3. GNANN, J. W. Jr.; W. E. GOETTER, A. M. ELLIOTT, et al.: Ceftriaxone: in vitro studies and clinical evaluation. Antimicrob. Agent Chemother. 22: 1-9, 1982
4. BITTNER, M. J.; D. L. DWORZACK, L. C. PREHEIM, et al.: Ceftriaxone therapy of serious bacterial infections in adults. Antimicrob. Agent Chemother. 23: 261-266, 1983
5. Streptococcus pneumoniae Haemophilus influenzae Jpn. J. Antibiotic 57: 475-480, 2004
6. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement M100-S14. Villanova, PA, 2004
7. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-sixth edition. M7-A6. Villanova, PA, 2003
8. Ceftriaxone (Ro 13-9904) Chemother. 32 (S-7): 98-125, 1984
9. KALAGER, T.; A. DIORANES, T. BERGAN, et al.: The pharmacokinetics of Ceftriaxone in serum, skin blister and thread fluid. J. Antimicrob. Chemother. 13: 479-485, 1984
10. ACHARYA, G.; C. CREVOISIER, T. BUTLER, et al.: Pharmacokinetics of ceftriaxone in patients with typhoid fever. Antimicrob. Agent Chemother. 38: 2415-2418, 1994
11. TAWARA, S.; S. MATSUMOTO, T. KAMIMURA, et al.: Effect of protein binding in serum on therapeutic efficacy of cephem antibiotics. Antimicrob. Agent Chemother. 36: 17-24, 1992
12. TANAKA, M.; H. NAKAYAMA, T. NOTOMI, et al.: Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates. Int. J. Antimicrob. Agent 24S: S15-S22, 2004
13. Meropenem 2002 Jpn. J. Antibiotic 57: 70-104, 2004